The health economics burden of sarcopenia: a systematic review

Sarcopenia, defined as a loss of muscle mass and function, is increasingly considered to be a major public health problem in the older population and in a range of clinical settings [1,2]. Indeed, the health consequences of sarcopenia include death, falls, new or prolonged hospitalizations, fractures, loss of mobility and physical function, a reduced quality of life [3 –6]. Interestingly, most of these outcomes have potential direct or indirect costs, both for the patient and the society. If a lot of studies assessing the clinical outcomes of sarcopenia have been published, far less studies assessing the costs of sarcopenia are available.

Source: Maturitas - November 12, 2018 Category: Primary Care Authors: Olivier Bruy ère, Charlotte Beaudart, Olivier Ethgen, Jean-Yves Reginster, Médéa Locquet Source Type: research